← Eichor
Study identifier: NCT04086368 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The FDR (Femoral Derotaton) Trail.

Condition: Idiopathic Increased Femoral Anteversion  ·  Sponsor: Oslo University Hospital

PhaseNA
Planned participants42
Who can joinAll sexes, 10 Years to 18 Years
Healthy volunteersYes

About this study

Femoral derotational osteotomy is the gold standard to correct symptomatic patients with increased femoral AV. There is no clear evidence in the literature supporting which surgical technique or implant that should be used. Traditionally these patients are treated with an open osteotomy and plate and screw fixation. In recent years intramedullary nailing with adolescent interlocking nail has been described and has shown to be a safe method. Percutaneous osteotomy and intramedullary nailing is considered a less invasive technique compared with open osteotomy and plate and screw fixation. The primary objective of this project, is to investigate if derotational osteotomy by means of percutaneous osteotomy and nailing is a safe and accurate method compared to an open approach and plating.

This description comes directly from the study's public registry record.

Talk to the study team

Anders Grønseth, M.D  ·  004791320205  ·  andgro@ous-hf.no

Joachim Horn, M.D PhD  ·  jhorn@ous-hf.no

Always discuss trial participation with your own doctor first.

Locations (1)

Oslo University HospitalOslo, NorwayRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04086368